Wordt geladen...
Innovative approaches to biologic development on the trail of CT-P13: biosimilars, value-added medicines, and biobetters
The biosimilar concept is now well established. Clinical data accumulated pre- and post-approval have supported biosimilar uptake, in turn stimulating competition in the biologics market and increasing patient access to biologics. Following technological advances, other innovative biologics, such as...
Bewaard in:
| Gepubliceerd in: | MAbs |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Taylor & Francis
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7889098/ https://ncbi.nlm.nih.gov/pubmed/33557682 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2020.1868078 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|